OPDIVO conc perf 100 mg/10ml flac
7680656600026
CH-65660
L01FF01
07.16.1.
Reimbursement limitations:
OPDIVO.01
Cancer bronchique non à petites cellules (CBNPC) 20461.01
En monothérapie dans le traitement du cancer …
1 / 3
google
Details
- Product number
- 6566002
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- nivolumabum 100 mg, natrii citras dihydricus, natrii chloridum, mannitolum, acidum penteticum, polysorbatum 80, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 25 mg.
Articles (1)
Opdivo 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
25.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1308.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2016
Authorization holder
Bristol-Myers Squibb SA
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 65660
- Drug name
- Opdivo, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FF01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 30/11/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OPDIVO conc perf 100 mg/10ml flac
- Description (DE)
- OPDIVO Inf Konz 100 mg/10ml Durchstf
- Market launch
- 30/11/2015
- Narcotic (BTM)
- No